Literature DB >> 27759774

RELATIONSHIP BETWEEN THE PRESENCE OF HELICOBACTER PYLORI WITH INFLAMMATORY ENDOSCOPIC CHANGES IN GASTRODUODENAL MUCOSA.

Irma Cláudia Saboya Ribeiro1,2, Luiz Fernandao Kubrusly1, Paulo Afonso Nunes Nassif1, Patrícia Fernanda Saboya Ribeiro2, Rodrigo de Oliveira Veras1, Aline Neppel1.   

Abstract

Background: The influence of Helicobacter pylori (HP) in inflammatory disorders of the digestive mucosa has been the subject of several studies since socioeconomic, personal and environmental factors were implicated in the bacteria transmission. Aim: To correlate the inflammatory endoscopic findings with HP infection and the onset of mucosal diseases mucous of the upper digestive tract. Method: Comparative observational study, in which were collected data from 2247 patients who underwent upper endoscopy and biopsies for HP with urease test. The patients were divided into two groups: HP+ and HP- (control) in which endoscopic findings were observed for the following changes: esophagitis, esophageal ulcer, gastritis, erosive gastritis, gastric ulcer, bulboduodenitis, bulbar ulcer and without disease.
Results: As for esophagitis, there was little disparity in the distribution favorable to HP+ group (HP+ =67.11% and HP- =69.89%) and esophageal ulcer (HP+ =0% and HP- =0, 21%). Gastritis was favorable to HP- group (HP+ =78.34% and HP- =73.63%), as well as erosive gastritis (HP+ = 67,11% and HP- = 64,55%), in bulboduodenitis (HP+ =1,87% and HP- 1,23%), in gastric ulcer (HP+ =2,14% and HP- =2,03%) and in the absence of alterations in the HP+ group (4.81%) with the HP- control group (6,30%), in which there was little disproportion in favor of HP- group, but without statistical significance. As for the bulbar ulcer (HP +=10.16% and HP- =4.48%), there was statistically significant (p=0.00001).
Conclusion: There is no difference between HP+ and HP- groups in inflammatory changes in endoscopic gastroduodenal mucosa, except for the relationship between HP and bulbar ulcer.

Entities:  

Mesh:

Year:  2016        PMID: 27759774      PMCID: PMC5074662          DOI: 10.1590/0102-6720201600030004

Source DB:  PubMed          Journal:  Arq Bras Cir Dig        ISSN: 0102-6720


  25 in total

1.  Gastric foveolar metaplasia and gastric heterotopia in the duodenum: no evidence of an etiologic role for Helicobacter pylori.

Authors:  Robert M Genta; R Shawn Kinsey; Anuradha Singhal; Smita Suterwala
Journal:  Hum Pathol       Date:  2010-07-24       Impact factor: 3.466

2.  [Helicobacter pylori and peptic disease: comparative study of the diagnostic methods].

Authors:  Alaor Caetano; Valter Nilton Felix; Fernando Tadeu Vanucci Coimbra; Arnaldo José Ganc
Journal:  Arq Gastroenterol       Date:  2008 Jul-Sep

3.  Helicobacter pylori genotypes may determine gastric histopathology.

Authors:  C Nogueira; C Figueiredo; F Carneiro; A T Gomes; R Barreira; P Figueira; C Salgado; L Belo; A Peixoto; J C Bravo; L E Bravo; J L Realpe; A P Plaisier; W G Quint; B Ruiz; P Correa; L J van Doorn
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

4.  Helicobacter pylori infection has no role in the pathogenesis of reflux esophagitis.

Authors:  B F Werdmuller; R J Loffeld
Journal:  Dig Dis Sci       Date:  1997-01       Impact factor: 3.199

5.  [Changes in ultra rapid urease test and histopathological examination for Helicobacter pylori by antisecretory drugs].

Authors:  L E Ferreira; G S Meirelles; R R Vieira; M A Bragagnolo Júnior; J M Chebli; A F de Souza
Journal:  Arq Gastroenterol       Date:  2001 Jan-Mar

6.  Meta-analysis: the relationship between Helicobacter pylori infection and gastro-oesophageal reflux disease.

Authors:  F Cremonini; S Di Caro; S Delgado-Aros; A Sepulveda; G Gasbarrini; A Gasbarrini; M Camilleri
Journal:  Aliment Pharmacol Ther       Date:  2003-08-01       Impact factor: 8.171

Review 7.  Review article: Helicobacter pylori and reflux disease.

Authors:  P Sharma; N Vakil
Journal:  Aliment Pharmacol Ther       Date:  2003-02       Impact factor: 8.171

8.  Helicobacter pylori infection is the major risk factor for atrophic gastritis.

Authors:  H Kawaguchi; K Haruma; K Komoto; M Yoshihara; K Sumii; G Kajiyama
Journal:  Am J Gastroenterol       Date:  1996-05       Impact factor: 10.864

9.  High degree of duodenal inflammation in Nigerians with functional dyspepsia.

Authors:  Sylvester Chuks Nwokediuko; Uchenna N Ijoma; Olive Obienu; Gideon E Anigbo; Okechukwu Okafor
Journal:  Clin Exp Gastroenterol       Date:  2013-12-31

10.  Minimal endoscopic changes in non-erosive reflux disease.

Authors:  Ana Carolina Ferreira Ratin; Ivan Roberto Bonotto Orso
Journal:  Arq Bras Cir Dig       Date:  2015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.